Australian clean technology developer Eden Innovations (ASX: EDE) has received an order worth approximately $350,000 from Swiss building materials company Holcim Ecuador.
The order is for the supply of the company’s concrete additive EdenCrete Pz7 to multiple Holcim plants.
It follows an initial order from Holcim in May for the supply of the same product to two of the company’s concrete plants in Ecuador and brings the total value of orders from Holcim companies in the US and Ecuador over the past nine months to approximately $500,000.
EdenCrete is a carbon-strengthened additive designed to enhance the performance characteristics of concrete by providing improved strength, abrasion resistance, reduced permeability, increased elasticity and reduced shrinkage.
EdenCrete Pz and EdenCrete Pz7 are high-concentration, lower-dosage alternatives to the original EdenCrete product most frequently used in concrete mixes with a high percentage of ordinary Portland cement or a higher percentage of low-cost, low-carbon-footprint pozzolanic cementitious materials.
Incorporating EdenCrete products into these cements can result in a cheaper, comparable concrete mix with a reduced greenhouse gas footprint.
The orders follow Holcim’s trial program that commenced in 2022, which Eden believes is an indication of growing global market interest in cost-effective, lower-carbon concretes.
Holcim is continuing trials of EdenCrete at its facilities, with a view to opening up new and significant markets for Eden.
The company has trials of EdenCrete Pz7 either underway or planned in Canada, Mexico and the United Kingdom.
Holcim is a cement, concrete and building materials company focused on de-carbonising materials that it markets worldwide.
The company operates in over 80 countries and generated an annual global revenue of approximately $44 billion in 2023.
The North American market represented 39% of this total (or approximately $17b), with other top markets including Europe (34%), Asia, the Middle East and Africa (16%) and South America (11%).
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。